CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network

Clinical Pharmacology and Therapeutics

Volumn 99, Issue 1, 2016, Pages 36-37

  Saito, Y ^a   Stamp, L K ^b   Caudle, K E ^c   Hershfield, M S ^d   McDonagh, E M ^e   Callaghan, J T ^f,g   Tassaneeyakul, W ^h   Mushiroda, T ⁱ   Kamatani, N ^j   Goldspiel, B R ^k   Phillips, E J ^l,m   Klein, T E ^e   Lee, M T M ^n,o,p  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^f RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g INDIANA UNIVERSITY   (United States)

^h KHON KAEN UNIVERSITY   (Thailand)

ⁱ RIKEN   (Japan)

^j Kuramae Orashion Bldg 9F   (Japan)

^k NATIONAL INSTITUTES OF HEALTH   (United States)

^l MURDOCH UNIVERSITY   (Australia)

^m VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

ⁿ RIKEN Center for Integrative Medical Sciences   (Japan)

^o INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^p CHINA MEDICAL UNIVERSITY   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; PHARMACOLOGICAL BIOMARKER;

ALLELE; CLINICAL DECISION MAKING; DRESS SYNDROME; ELECTRONIC MEDICAL RECORD; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; GOUT; HUMAN; PHARMACOGENETICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; DRUG ADMINISTRATION; GENETICS; STANDARDS;

ALLOPURINOL; BIOMARKERS, PHARMACOLOGICAL; DRUG ADMINISTRATION SCHEDULE; GENOTYPE; GUIDELINES AS TOPIC; HLA-B ANTIGENS; HUMANS;

EID: 84955325490     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1002/cpt.161     Document Type: Review

References (6)

1. Relling, M.V., Klein, T.E. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network. Clin. Pharmacol. Ther. 89, 464-467 (2011).
2. Hershfield, M.S. et al. Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing. Clin. Pharmacol. Ther. 93, 153-158 (2013).
3. Khanna, D. et al. 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res. 64, 1447-1461 (2012).
4. Shuldiner, A.R. et al. The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation. Clin. Pharmacol. Ther. 94, 207-210 (2013).
5. Wilke, R.A. et al. The emerging role of electronic medical records in pharmacogenomics. Clin. Pharmacol. Ther. 89, 379-386 (2011).
6. Kullo, I.J., Jarvik, G.P., Manolio, T.A., Williams, M.S., Roden, D.M. Leveraging the electronic health record to implement genomic medicine. Genet. Med. 15, 270-271 (2013).